REPLINVI Trademark

Trademark Overview


On Wednesday, January 31, 2018, a trademark application was filed for REPLINVI with the United States Patent and Trademark Office. The USPTO has given the REPLINVI trademark a serial number of 79228273. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Tuesday, October 12, 2021. This trademark is owned by NOVARTIS AG. The REPLINVI trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the pr...
replinvi

General Information


Serial Number79228273
Word MarkREPLINVI
Filing DateWednesday, January 31, 2018
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateTuesday, October 12, 2021
Registration Number5548030
Registration DateTuesday, August 28, 2018
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 12, 2018

Trademark Statements


Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateTuesday, October 12, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events


Event DateEvent Description
Sunday, September 11, 2022NOTIFICATION PROCESSED BY IB
Sunday, February 27, 2022NOTIFICATION PROCESSED BY IB
Wednesday, November 3, 2021NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Wednesday, November 3, 2021DEATH OF INTERNATIONAL REGISTRATION
Friday, October 19, 2018NOTIFICATION PROCESSED BY IB
Saturday, September 29, 2018FINAL DISPOSITION NOTICE SENT TO IB
Saturday, September 29, 2018FINAL DISPOSITION PROCESSED
Thursday, September 27, 2018GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, August 28, 2018REGISTERED-PRINCIPAL REGISTER
Tuesday, June 12, 2018PUBLISHED FOR OPPOSITION
Friday, June 8, 2018NOTIFICATION PROCESSED BY IB
Wednesday, May 23, 2018NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, May 23, 2018NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, May 23, 2018NOTICE OF PUBLICATION
Thursday, May 10, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, April 27, 2018ASSIGNED TO EXAMINER
Thursday, March 15, 2018APPLICATION FILING RECEIPT MAILED
Sunday, March 11, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, March 9, 2018LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, March 8, 2018SN ASSIGNED FOR SECT 66A APPL FROM IB